Possible scenario
Incremental Scientific Progress
25% Chance
The result remains scientifically interesting but does not immediately change drug-discovery economics. Researchers proceed through peer review, replication, and functional characterization, limiting the near-term financial impact.
Secondary impacts
- Healthcare +0.2%
- Technology +0.2%
Tickers
- TWST+1.1%
- RXRX+0.6%
Portfolio impact
S&P 500+0.1%
Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.
Keeping an eye on this scenario?
Tilt can alert you when its probability or impact shifts, or send you a recommendation when it crosses a threshold.